The current price of RCEL is $16.59 — it has increased by 5.80% since the previous close. Data as of Nov 6, 2026.
RCEL is up 6.01% over the past week, up 27.13% over the past month and up 340.05% over the past year. The price is above its 200-day moving average of $6.85.
Analysts' average 12-month price target for RCEL is $11.50, which implies 30.68% downside from the current price. Individual estimates range from $11.00 to $12.00.
Of the 3 analysts covering Avita Medical Inc., 3 rate it a buy. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Avita Medical Inc. has a market capitalization of $412.14M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Avita Medical Inc. posted a loss of $0.20 per share against an estimate of -$0.2394, beating expectations by 16.46%. Upcoming reports are listed in the earnings calendar.
Avita Medical Inc. reported revenue of $26.11M in its most recent quarter, which has increased by 53.05% compared with the same quarter a year earlier. Analysts had expected $22.35M.
Avita Medical Inc. has not paid any dividends over the past year.
Companies most comparable to Avita Medical Inc. include Ovid Therapeutics Inc., Shattuck Labs, Inc., Quipt Home Medical Corp., Apyx Medical Corporation and Fonar Corp.
In the latest trading session RCEL moved between $16.12 and $18.00, a range of 11.33% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Avita Medical Inc. shows a buy rating today and a strong buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Avita Medical Inc. is buy. Technical ratings are indicators, not investment advice.
Over the past 52 weeks RCEL has traded between $3.22 and $18.07. The current price is 8.19% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.